Pharma-Bio Serv (PBSV) Return on Capital Employed (2016 - 2025)
Historic Return on Capital Employed for Pharma-Bio Serv (PBSV) over the last 15 years, with Q4 2025 value amounting to 0.05%.
- Pharma-Bio Serv's Return on Capital Employed rose 400.0% to 0.05% in Q4 2025 from the same period last year, while for Oct 2025 it was 0.05%, marking a year-over-year increase of 400.0%. This contributed to the annual value of 0.05% for FY2025, which is 300.0% up from last year.
- Per Pharma-Bio Serv's latest filing, its Return on Capital Employed stood at 0.05% for Q4 2025, which was up 400.0% from 0.05% recorded in Q3 2025.
- In the past 5 years, Pharma-Bio Serv's Return on Capital Employed ranged from a high of 0.08% in Q1 2021 and a low of 0.21% during Q3 2022
- Over the past 5 years, Pharma-Bio Serv's median Return on Capital Employed value was 0.04% (recorded in 2024), while the average stood at 0.03%.
- As far as peak fluctuations go, Pharma-Bio Serv's Return on Capital Employed tumbled by -2700bps in 2022, and later soared by 2900bps in 2023.
- Pharma-Bio Serv's Return on Capital Employed (Quarter) stood at 0.16% in 2021, then skyrocketed by 139bps to 0.06% in 2022, then dropped by -3bps to 0.06% in 2023, then crashed by -243bps to 0.09% in 2024, then skyrocketed by 40bps to 0.05% in 2025.
- Its Return on Capital Employed stands at 0.05% for Q4 2025, versus 0.05% for Q3 2025 and 0.05% for Q2 2025.